- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Valiant Laboratories Limited — Board Meeting, 10-08-2026: Outcome of Board Meeting
10-08-2026 | 08:21 pm
10-08-2026 | 08:21 pm
Valiant Laboratories' board has approved the audited financial results for the quarter ended June 30, 2026. Consolidated Revenue hit ₹115.29 Cr, with Net Profit at ₹21.10 Cr. EPS for the quarter stands at ₹3.89.
No comments yet. Be the first to comment!